Jessica Hope Roark

Array ( [id] => 6884680 [patent_doc_number] => 20010038840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-08 [patent_title] => 'Method for the treatment of fibrosis' [patent_app_type] => new [patent_app_number] => 09/846325 [patent_app_country] => US [patent_app_date] => 2001-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3413 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20010038840.pdf [firstpage_image] =>[orig_patent_app_number] => 09846325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6462498 [patent_doc_number] => 20020150586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof' [patent_app_type] => new [patent_app_number] => 09/847637 [patent_app_country] => US [patent_app_date] => 2001-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7289 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150586.pdf [firstpage_image] =>[orig_patent_app_number] => 09847637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6597787 [patent_doc_number] => 20020042362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Human B-cell translocation genes-2 and 3 antibodies' [patent_app_type] => new [patent_app_number] => 09/843846 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19927 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042362.pdf [firstpage_image] =>[orig_patent_app_number] => 09843846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159553 [patent_doc_number] => 20020147326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Hexameric fusion proteins and uses therefor' [patent_app_type] => new [patent_app_number] => 09/845899 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 14370 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147326.pdf [firstpage_image] =>[orig_patent_app_number] => 09845899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033346 [patent_doc_number] => 20020019345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Method of treating graft rejection using inhibitors of CCR5 function' [patent_app_type] => new [patent_app_number] => 09/834996 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12276 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019345.pdf [firstpage_image] =>[orig_patent_app_number] => 09834996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032071 [patent_doc_number] => 20020018776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Method of treating graft rejection using inhibitors of CXCR3 function' [patent_app_type] => new [patent_app_number] => 09/835103 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14136 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20020018776.pdf [firstpage_image] =>[orig_patent_app_number] => 09835103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6597932 [patent_doc_number] => 20020042370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Method of treating graft rejection using inhibitors of CCR2 function' [patent_app_type] => new [patent_app_number] => 09/835087 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12136 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042370.pdf [firstpage_image] =>[orig_patent_app_number] => 09835087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240772 [patent_doc_number] => 06682741 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => '2 microglobulin fusion proteins and high affinity variants' [patent_app_type] => B1 [patent_app_number] => 09/719243 [patent_app_country] => US [patent_app_date] => 2001-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 13948 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/682/06682741.pdf [firstpage_image] =>[orig_patent_app_number] => 09719243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5802107 [patent_doc_number] => 20020010125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Assay for agents that induce chemokinesis' [patent_app_type] => new [patent_app_number] => 09/810010 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10765 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010125.pdf [firstpage_image] =>[orig_patent_app_number] => 09810010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1260382 [patent_doc_number] => 06663863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-16 [patent_title] => 'Method of inhibiting stenosis and restenosis' [patent_app_type] => B2 [patent_app_number] => 09/809739 [patent_app_country] => US [patent_app_date] => 2001-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 39 [patent_no_of_words] => 21609 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 389 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/663/06663863.pdf [firstpage_image] =>[orig_patent_app_number] => 09809739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7092400 [patent_doc_number] => 20010033841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Modulating platelet function' [patent_app_type] => new [patent_app_number] => 09/804606 [patent_app_country] => US [patent_app_date] => 2001-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5503 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20010033841.pdf [firstpage_image] =>[orig_patent_app_number] => 09804606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6900222 [patent_doc_number] => 20010009898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-26 [patent_title] => 'Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis' [patent_app_type] => new [patent_app_number] => 09/801414 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2481 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20010009898.pdf [firstpage_image] =>[orig_patent_app_number] => 09801414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6934248 [patent_doc_number] => 20010055592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-27 [patent_title] => 'Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis' [patent_app_type] => new [patent_app_number] => 09/802305 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2484 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20010055592.pdf [firstpage_image] =>[orig_patent_app_number] => 09802305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6328983 [patent_doc_number] => 20020198143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'B7-like polynucleotides, polypeptides, and antibodies' [patent_app_type] => new [patent_app_number] => 09/790622 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 113488 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198143.pdf [firstpage_image] =>[orig_patent_app_number] => 09790622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289203 [patent_doc_number] => 20020054875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Therapeutic methods that target fractalkine or CX3CR1' [patent_app_type] => new [patent_app_number] => 09/789482 [patent_app_country] => US [patent_app_date] => 2001-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22791 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20020054875.pdf [firstpage_image] =>[orig_patent_app_number] => 09789482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936560 [patent_doc_number] => 20020061834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Human G-protein Chemokine receptor (CCR5) HDGNR10' [patent_app_type] => new [patent_app_number] => 09/779880 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 180387 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061834.pdf [firstpage_image] =>[orig_patent_app_number] => 09779880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5873880 [patent_doc_number] => 20020048786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Human G-protein Chemokine Receptor HDGNR10' [patent_app_type] => new [patent_app_number] => 09/779879 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 174857 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048786.pdf [firstpage_image] =>[orig_patent_app_number] => 09779879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418309 [patent_doc_number] => 06512095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-01-28 [patent_title] => 'Molecules designated B7L-1' [patent_app_type] => B2 [patent_app_number] => 09/778510 [patent_app_country] => US [patent_app_date] => 2001-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21906 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/512/06512095.pdf [firstpage_image] =>[orig_patent_app_number] => 09778510 [rel_patent_id] =>[rel_patent_doc_number] =>)